Results 221 to 230 of about 477,025 (329)

Face to Face With Renal Cell Carcinoma: A Case Report. [PDF]

Cureus
Andrade MA, Caires F, Duarte CC, Santana C, Saldanha C.   +4 more
europepmc   +1 more source

Targeting MAN1B1 potently enhances bladder cancer antitumor immunity via deglycosylation of CD47

Cancer Communications, EarlyView.
Abstract Background Only a few bladder cancer patients benefit from anti‐programmed cell death protein 1/programmed cell death ligand 1 immunotherapy. The cluster of differentiation 47 (CD47) plays an important role in tumor immune evasion. CD47 is a highly glycosylated protein, however, the mechanisms governing CD47 glycosylation and its potential ...
Jie Zhang, Chen Zhang, Ruichen Zang, Weiwu Chen, Yining Guo, Haofei Jiang, Jing Le, Kunyu Wang, Haobo Fan, Xudong Wang, Sisi Mo, Peng Gao, Wenhao Guo, Xinrong Jiang, Fengbin Gao, Junming Jiang, Juyan Zheng, Yuxing Chen, Yicheng Chen, Yanlan Yu, Guoqing Ding   +20 more
wiley   +1 more source

STUDY OF IN VITRO EFFECT OF MPA ON ESTABLISHED CELL LINE FROM HUMAN RENAL CELL CARCINOMA

, 1985
Shuji Yamashita
openalex   +2 more sources

Phytochemical Investigation and Biological Evaluation of Disynaphia filifolia: A Novel Source of Tremetone in Asteraceae

Chemistry &Biodiversity, EarlyView.
ABSTRACT Chemical investigation of Disynaphia filifolia (Hassl.) R.M. King & H. Rob. (Asteraceae) led to the isolation of eight compounds, with tremetone being the major metabolite recovered. Tremetone has been suggested as the toxic compound in Ageratina altissima and Isocoma pluriflora, two species of the Asteraceae family. Although D.
Yasmin Rodrigues Chierici, Anderson Valdiney Gomes Ramos, Drielli Rhiane Peres Colhado Areas, Alana Carla Battistella, Solange Maria Cottica, Tatiana Shioji Tiuman, Helena Mannochio‐Russo, Ana Lucia Tasca Gois Ruiz, Mary Ann Foglio, Marta Regina Barrotto do Carmo, Maria Helena Sarragiotto, Debora Cristina Baldoqui   +11 more
wiley   +1 more source

RENAL CELL CARCINOMA WITH NON-SPECIFIC Ig-G ANTIBODY AND ITS TREATMENT

, 1985
Hideshi Miyakita, Yoshihiro Nagata, Hidechika Kinoshita, Nobuo Kawamura, Miho Hida   +4 more
openalex   +2 more sources

Proteomics and succinylation modification characterization in clear cell renal cell carcinoma. [PDF]

Discov Oncol
Yue D, Zheng M.
europepmc   +1 more source

Ethnomedicinal Uses, Phytochemistry, Pharmacological Activities, and Toxicology of the Subfamily Gomphrenoideae (Amaranthaceae): A Comprehensive Review

Chemistry &Biodiversity, EarlyView.
ABSTRACT The subfamily Gomphrenoideae is composed of about 480 accepted species, many of which have been historically used as medicinal plants, reason why they have been studied in terms of chemical profile, biological activity, and safety. This review consolidates the advances in research on this subfamily over the past 47 years, emphasizing its ...
Dayanna Isabel Araque Gelves, Giulia Cristina de Andreoli Souza, Alvaro Jose Hernandez Tasco, Marcos José Salvador   +3 more
wiley   +1 more source

CLINICOPATHOLOGICAL OBSERVATION ON RENAL CELL CARCINOMA

, 1982
Fumio Yoneda, Go Akagi, Hisashi Otsuka
openalex   +2 more sources

Renal Cell Carcinoma: A Review. [PDF]

JAMA
Rose TL, Kim WY.
europepmc   +1 more source

Evolving Recommendations for Patient Populations Among Oncology Medicines: A Quantitative and Qualitative Analysis

Clinical Pharmacology &Therapeutics, EarlyView.
After a medicine has been tested in pivotal trials, regulators, health technology assessment (HTA) organizations, and professional societies make decisions about the patients best served by the medicine. This study assesses how the patient populations for oncology medicines (2010–2023) are defined (1) at trial, (2) regulatory submission, (3) upon ...
Milou A. Hogervorst, Rick A. Vreman, Theresa A. Oduol, Aukje K. Mantel‐Teeuwisse, Wim G. Goettsch, Aaron S. Kesselheim   +5 more
wiley   +1 more source